International Trade Today is a service of Warren Communications News.
Subscriber Login
FDA
to
Refine Category Search
Clear Terms

Search Primer

Multi-word term: Place inside quotes to ensure an exact match together (e.g. "forced labor").

Term list: Separate terms with spaces, not commas or semicolons to find either word (e.g. AD/CVD CBP).

Acronyms: Use all capital letters (e.g., ACE).

Required term: If a term must be included in any resulting articles, prefix it with a plus sign (e.g., tariffs +Canada).

Excluded term: If a term should be excluded from any articles being found, prefix it with a minus sign (e.g., FDA -alert).

Simplest form: Use the simplest form of a term (e.g. "metal" instead of "metals" or "entity list" instead of "entity listing" or "entity listed").

FDA to Hold Virtual Meeting on DSCSA Implementation
November 4, 2022 |FDA

FDA will hold a virtual public meeting Dec. 7-8 on implementation of the Drug Supply Chain Security Act and readiness for requirements that will take effect in 2023, it said in a notice released Nov. 4. Topics to be discussed include “stakeholder experiences with implementation and overall readiness regarding implementation of enhanced drug distribution security requirements” that take effect Nov. 27, 2023, as well as “standards for the interoperable data exchange of product tracing information, requests for product tracing information or verification from FDA for the purpose of investigating suspect or illegitimate products or for recalls, steps taken to build capacity for package-level tracing, pharmaceutical distribution supply chain best practices, and, in general, the impact that the [DSCSA] requirements would have on public health, including patient safety and access to prescription drugs, and on stakeholders, in terms of costs, benefits, and regulatory burden.”